Back to Journals » Cancer Management and Research
Cancer Management and Research
ISSN: 1179-1322
Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.
An international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4628)
- Volume 16, 2024 (34)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Latest articles:
- 5 records -
Unveiling Intricacies of DIEP Breast Reconstruction Post Early Breast Cancer: A Deep Dive into a Case of Unforeseen Complications
Xie L, Kong X, Gao J
Cancer Management and Research 2024, 16:337-345
Published Date: 18 April 2024
Linking EMT Status of Circulating Tumor Cells to Clinical Outcomes in Lung Cancer
Huangfu Y, Guo J, Zhao Y, Cao X, Han L
Cancer Management and Research 2024, 16:325-336
Published Date: 18 April 2024
Pre- and Post-Treatment Quality of Life Among Patients with Advanced Stage Cervical Cancer at Tikur Anbessa Specialized Hospital, Ethiopia
Teshome R, Yang I, Woldetsadik E, Girma E, Higgins M, Wells J
Cancer Management and Research 2024, 16:311-323
Published Date: 17 April 2024
Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update
Liu S, Zhao H, Li X
Cancer Management and Research 2024, 16:299-310
Published Date: 8 April 2024
Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials
Yeo W, Ngai NTY, Yip CCH, Mo FKF, Yeo VA, Ko JWH, Li LV, Lau TKH, Lai KT, Pang E, Yip CH, Yeo HL, Kwok CCH, Ko SWY, Molassiotis A
Cancer Management and Research 2024, 16:283-297
Published Date: 8 April 2024